前沿论文｜CELL INTELLIGENCE

Full-length recombinant antibodies from Escherichia coli: production, characterization, effector function (Fc) engineering, and clinical evaluation.

PubMed 2022/01/01 发表MAbsQ1 · IF 7.9（JCR 2025）

46.9分

★★★☆☆

站内排序·非疗效

Current Developments of CAR-T and CAR-NK Cell Therapies for Ovarian Cancer.

PubMed 2025/12/27 发表Stem Cell Rev RepQ2 · IF 4.9（JCR 2025）

44.4分

★★☆☆☆

站内排序·非疗效

Update on immune-based therapy strategies targeting cancer stem cells.

PubMed 2023/09/12 发表Cancer MedQ2 · IF 3.5（JCR 2025）

31.6分

★☆☆☆☆

站内排序·非疗效

前沿论文 3